Overture Life, a Madrid, Spain-based IVF process automation startup, raised $15M in Series B funding.
The round, which brought total fundraising to $37M, was led by Octopus Ventures, with participation from GV, as well as existing investors Khosla Ventures, Felicis Ventures, and Marc Benioff.
The company intends to use the funds to increase its operations in Europe and the US and begin commercialization of its first products.
Led by Martin Varsavsky, CEO, Overture Life is developing medical devices and novel embryo testing methodologies that will automate all stages of the IVF process, lowering costs and increasing throughput for IVF practitioners. The devices are being developed in its facilities located in Madrid and Barcelona. Overture currently employs 60 multidisciplinary specialists across the fields of software, microfluidics, robotics, embryology, and reproductive medicine.
FinSMEs
27/05/2021